The company also allegedly generated fake positive reviews posted by hired individuals, employees, and family members
Lab Clarity or Inclusion: Labs included or priced transparently up front
Dysesthesia A notable finding was dysesthesia (an abnormal sensation such as tingling, burning, or numbness), reported in up to 20.9% of participants at the 12 mg dose
For GLP-1 medications, insurers may require evidence that the patient has tried other treatments or that the medication is essential for managing weight loss in the presence of other conditions like type 2 diabetes, hypertension, or cardiovascular disease
Dose titration schedules significantly impact nausea incidence
resM can say it "supports metabolism." It cannot say it "treats obesity" or "prevents diabetes." This is why you see careful language on the product page and why the product carries the standard disclaimer that it has not been evaluated by the FDA